Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tang

Showing results (591-600 of 619) with videos related to

Pageof 62
Sort By:
Biorxiv : the Preprint Server for Biology|June 4, 2026
A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancerKathryn E Maraszek, Arwen A Tisdale, Hunter D Reavis, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cellsJason S Kirk, Jie Wang, Amanda Tracz, et al.
Cell Stem Cell|June 15, 2024
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cellsJason S Kirk, Jie Wang, Mark Long, et al.
Oncogene|January 26, 2016
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell propertiesA N Paranjape, R Soundararajan, S J Werden, et al.
Cancer Heterogeneity and Plasticity|November 12, 2025
Advancing Cancer Biology: Highlights from the 2025 FASEB SRC on Cellular Plasticity in CancerHans Clevers, Ankur Sharma, Sendurai A Mani, et al.
Nature Communications|June 6, 2020
Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancerQiuhui Li, Bigang Liu, Hsueh-Ping Chao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Defining the priority of using 18F-FDG PET for recurrent cervical cancerTzu-Chen Yen, Lai-Chu See, Ting-Chang Chang, et al.
Nature Communications|December 4, 2019
LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancerQiuhui Li, Bigang Liu, Hsueh-Ping Chao, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 29, 2024
Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation DevicesMichael Yaoyao Yin, Eleni Maneta, Christos P Kyriakopoulos, et al.
Molecular Cell|May 3, 2016
ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor GrowthBoyko S Atanassov, Ryan D Mohan, Xianjiang Lan, et al.
Pageof 62

Showing results (591-600 of 619) with videos related to

Sort By:
Pageof 62
Biorxiv : the Preprint Server for Biology|June 4, 2026
A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancerKathryn E Maraszek, Arwen A Tisdale, Hunter D Reavis, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cellsJason S Kirk, Jie Wang, Amanda Tracz, et al.
Cell Stem Cell|June 15, 2024
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cellsJason S Kirk, Jie Wang, Mark Long, et al.
Oncogene|January 26, 2016
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell propertiesA N Paranjape, R Soundararajan, S J Werden, et al.
Cancer Heterogeneity and Plasticity|November 12, 2025
Advancing Cancer Biology: Highlights from the 2025 FASEB SRC on Cellular Plasticity in CancerHans Clevers, Ankur Sharma, Sendurai A Mani, et al.
Nature Communications|June 6, 2020
Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancerQiuhui Li, Bigang Liu, Hsueh-Ping Chao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Defining the priority of using 18F-FDG PET for recurrent cervical cancerTzu-Chen Yen, Lai-Chu See, Ting-Chang Chang, et al.
Nature Communications|December 4, 2019
LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancerQiuhui Li, Bigang Liu, Hsueh-Ping Chao, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 29, 2024
Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation DevicesMichael Yaoyao Yin, Eleni Maneta, Christos P Kyriakopoulos, et al.
Molecular Cell|May 3, 2016
ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor GrowthBoyko S Atanassov, Ryan D Mohan, Xianjiang Lan, et al.
Pageof 62